Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Canney, P.
123  Ergebnisse:
Personensuche X
?
1

Detailed Sub-study Analysis of the SECRAB Trial: Quality of..:

Fernando, I.N. ; Lax, S. ; Bowden, S.J....
Clinical Oncology.  35 (2023)  6 - p. 397-407 , 2023
Link: https://doi.org/10.1016/..
 
?
2

The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality ass..:

On behalf of the SUPREMO Trial Management Group ; Thomas, J. S. ; Hanby, A. M....
Breast Cancer Research and Treatment.  163 (2017)  1 - p. 63-69 , 2017
Link: https://doi.org/10.1007/..
 
?
3

A Prospective Randomised Phase III Clinical Trial Testing t..:

Canney, P. ; Murray, E. ; Dixon-Hughes, J...
Clinical Oncology.  27 (2015)  8 - p. 460-464 , 2015
Link: https://doi.org/10.1016/..
 
?
4

1809 Results of the OPTIMA (Optimal Personalized Treatment ..:

Stein, R.C. ; Makris, A. ; Hughes-Davies, L....
European Journal of Cancer.  51 (2015)  - p. S268 , 2015
Link: https://doi.org/10.1016/..
 
?
5

1231 Cost-effectiveness analysis of the use of pegfilgrasti..:

Chapman, H. ; Bloomfield, D. ; Cameron, D....
European Journal of Cancer.  51 (2015)  - p. S183-S184 , 2015
Link: https://doi.org/10.1016/..
 
?
6

Selecting Breast Cancer Patients for Chemotherapy: The Open..:

Bartlett, J. ; Canney, P. ; Campbell, A....
Clinical Oncology.  25 (2013)  2 - p. 109-116 , 2013
Link: https://doi.org/10.1016/..
 
?
7

194 A Phase II Study of Trastuzumab Plus Capecitabine with ..:

Urruticoechea, A. ; Canney, P. ; Separovic, R....
European Journal of Cancer.  48 (2012)  - p. S97 , 2012
Link: https://doi.org/10.1016/..
 
?
8

200 TACT2 Trial in Early Breast Cancer (EBC): Differential ..:

Canney, P. ; Coleman, R. ; Morden, J....
European Journal of Cancer.  48 (2012)  - p. S102 , 2012
Link: https://doi.org/10.1016/..
 
?
9

Synchronous Chemo-radiation Can Reduce Local Recurrence in ..:

Fernando, I. ; Bowden, S.J. ; Brookes, C.L....
European Journal of Cancer.  47 (2011)  - p. 2 , 2011
Link: https://doi.org/10.1016/..
 
?
10

What are the minimal standards of radiotherapy planning and..:

MacLeod, N. ; McIntyre, A. ; Canney, P.A.
The Breast.  19 (2010)  3 - p. 172-175 , 2010
Link: https://doi.org/10.1016/..
 
?
11

PCN96 A UK COST-UTILITY ANALYSIS OF PACLITAXEL ALBUMIN COMP..:

McLeod, EJ ; Lloyd, A ; Samyshkin, Y..
Value in Health.  13 (2010)  7 - p. A269 , 2010
Link: https://doi.org/10.1016/..
 
?
12

Does HER-2 Over-expressing Breast Cancer have a Predilectio..:

Paterson, C. ; Mcintyre, A. ; Canney, P.A.
Clinical Oncology.  21 (2009)  8 - p. 635-636 , 2009
Link: https://doi.org/10.1016/..
 
?
13

Elucidating the Role of Chest Wall Irradiation in 'Intermed..:

Kunkler, I.H. ; Canney, P. ; van Tienhoven, G..
Clinical Oncology.  20 (2008)  1 - p. 31-34 , 2008
Link: https://doi.org/10.1016/..
 
?
14

Improving Adjuvant Chemotherapy in Breast Cancer — Can We G..:

Johnson, L. ; Cameron, D. ; Barrett-Lee, P...
Clinical Oncology.  19 (2007)  8 - p. 593-595 , 2007
Link: https://doi.org/10.1016/..
 
?
15

P88 MRC/EORTC (BIG 2–04) SUPREMO – a phase III trial assess..:

Kunkler, I. ; Canney, P. ; van Tienhoven, G....
The Breast.  16 (2007)  - p. S37 , 2007
Link: https://doi.org/10.1016/..
 
1-15